An attacker within BLE communication range can monopolize the device's
only available BLE connection slot, preventing legitimate users or
applications from establishing a connection.

Project Subscriptions

No data.

Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information: https://www.apollopharmacy.in/contact-us CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog:  https://www.cisa.gov/news-events/news/understanding-bluetooth-technology

History

Fri, 19 Jun 2026 00:15:00 +0000

Type Values Removed Values Added
Description An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Title Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
Weaknesses CWE-862
References
Metrics cvssV3_1

{'score': 6.5, 'vector': 'CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H'}

cvssV4_0

{'score': 7.1, 'vector': 'CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: icscert

Published:

Updated: 2026-06-18T23:45:34.263Z

Reserved: 2026-06-10T21:21:12.261Z

Link: CVE-2026-52866

cve-icon Vulnrichment

No data.

cve-icon NVD

No data.

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

Updated: 2026-06-19T01:30:16Z

Weaknesses